☆ 4.7 Letter

Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment

ANNALS OF ONCOLOGY (2011)

Related references

Note: Only part of the references are listed.

Article Oncology

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group-Directed Intergroup Trial S0205

Philip A. Philip et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Add to Collection

Article Oncology

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group

Malcolm J. Moore et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Add to Collection

Article Gastroenterology & Hepatology

The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness - Poor prognosis in patients with pancreatic ductal adenocarcinoma

S Ueda et al.

PANCREAS (2004)

Add to Collection

Article Gastroenterology & Hepatology

Mechanisms of resistance to erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells

JP Arnoletti et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.